Anna Estival

Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes

Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations

Randomized phase IIb clinical trial of continuation or non-continuation with six cycles of temozolomide after the first six cycles of standard first-line treatment in patients with glioblastoma: A Spanish research group in neuro-oncology (GEINO) trial.

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines